Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
06/2003
06/12/2003US20030108934 Isolated nucleic acids; transgenic animals; anticancer agents
06/12/2003US20030108933 Novel serine-threonine kinase-3
06/12/2003US20030108916 Screening analysis using nucleic acids; antibodies, transgenic animals; antiproliferative agents; induction cell cycle delay
06/12/2003US20030108908 Hansenula polymorpha mutants and process for the preparation of recombinant proteins using the same
06/12/2003US20030108907 Nucleic acids, proteins, and antibodies
06/12/2003US20030108906 Signal transduction, gene expression of pain sequences; genetic engineering
06/12/2003US20030108894 Novel polypeptide-atp-dependent helicase protein 68 and the polynucleotide encoding said polypeptide
06/12/2003US20030108891 Transacylases of the paclitaxel biosynthetic pathway
06/12/2003US20030108889 Mutations; cloning; immunoglobulins; genetic engineering
06/12/2003US20030108886 Autogene nucleic acids encoding a secretable RNA polymerase
06/12/2003US20030108885 Methods and compositions for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs
06/12/2003US20030108883 Protein tyrosine phosphatase 1B (PTP1B); insulin resistance
06/12/2003US20030108880 Gene expression regulation
06/12/2003US20030108873 Systems for the detection of target sequences
06/12/2003US20030108869 Leucine zipper domains of reporter molecule hydrolyze penicillin or cephalosporin substrates; gene expression
06/12/2003US20030108642 Penicillium funiculosum strain useful for the production of enzymes
06/12/2003US20030108641 Improving rheological properties and quality of bread, alimentary paste products, noodles; strength and stability
06/12/2003US20030108623 Cancer treatment composition and method using signal transduction modulators and natural plant essential oils as synergists for conventional treatments
06/12/2003US20030108622 Prophylactic or therapeutic treatment of soft tissue cancer, e.g. breast cancer; improving the effective treatment and reducing the adverse side effects of current anticancer therapy; antiproliferative, -carcinogenic agents
06/12/2003US20030108572 Antigenic preparations and the isolation of such preparations
06/12/2003US20030108538 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
06/12/2003US20030108530 Antisense inhibiting melanoma invasion and functional analogs thereof
06/12/2003US20030106655 Process for treating with enzyme
06/12/2003CA2469566A1 Hyaluronan synthases and methods of making and using same
06/12/2003CA2469477A1 Phenotypic screen of chimeric proteins
06/12/2003CA2468853A1 Prenyltransferase from plants
06/12/2003CA2468727A1 Variants of adp-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters
06/12/2003CA2468457A1 Enzyme activity profiles
06/12/2003CA2464897A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/11/2003WO2003091430A1 GLUCOSE DEHYDROGENASE β-SUBUNIT AND DNA ENCODING THE SAME
06/11/2003EP1318200A2 Methods for producing optically active alcohols
06/11/2003EP1318197A1 Thermotolerant ribonuclease h
06/11/2003EP1318196A1 Amino acid producing strains belonging to the genus Escherichia and method for producing amino acid
06/11/2003EP1318193A2 D-amidase from Variovorax
06/11/2003EP1318192A2 Prenyltransferase from Arabidopsis
06/11/2003EP1317555A1 Rat cathepsin, dipeptidyl peptidase i (dppi): crystal structure, inhibitors and its uses
06/11/2003EP1317554A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof
06/11/2003EP1317553A2 Pdes and uses thereof
06/11/2003EP1317552A2 23430, a novel human ubiquitin hydrolase family member and uses therefor
06/11/2003EP1317551A2 Human phospholipases and polynucleotides encoding the same
06/11/2003EP1317550A2 Nucleotide sequences which code for the ppsa gene
06/11/2003EP1317549A1 Isolation and sequencing of the ptsi gene of c. glutamicum
06/11/2003EP1317548A2 Transglutaminase gene products
06/11/2003EP1317547A1 Isolation and sequencing of the pknb gene of c. glutamicum
06/11/2003EP1317546A2 Nucleotide sequences which code for the gora gene
06/11/2003EP1317545A2 Nucleotide sequences coding for the pknd gene
06/11/2003EP1317539A2 Directed evolution method
06/11/2003EP1317535A2 Constructs and their use in metabolic pathway engineering
06/11/2003EP1317533A1 Lubricated granules
06/11/2003EP1317532A2 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
06/11/2003EP1317531A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof
06/11/2003EP1317530A2 27877, a phospholipase and uses therefor
06/11/2003EP1317529A1 Crystal structure of pantothenate synthetase
06/11/2003EP1317528A2 Lipoxygenase
06/11/2003EP1317527A2 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
06/11/2003EP1317433A2 Inhibitors of glycogen synthase kinase 3
06/11/2003EP1317414A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
06/11/2003EP1317282A2 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
06/11/2003EP1317250A1 Cosmetic compositions
06/11/2003EP1317182A1 Pest control system
06/11/2003EP1062349B1 Diisopropyl fluorophosphatase and the utilization and production thereof
06/11/2003EP0851914B1 Purified mannanase from bacillus amyloliquefaciens and method of preparation
06/11/2003EP0817838B1 Alkaline lipolytic enzyme
06/11/2003EP0750511B1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
06/11/2003EP0707641B1 An enzyme with protease activity
06/11/2003EP0694075B1 Thermostable dna topoisomerase v
06/11/2003EP0665886B1 Cyclin complex rearrangement and uses related thereto
06/11/2003CN1423748A Solution and crystal structures of MMP-13 active sidte and uses thereof
06/11/2003CN1423703A Process for producing L-amino via fermentation method
06/11/2003CN1423699A Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
06/11/2003CN1423694A Site-directed mutagenesis of escherichia coli phytase
06/11/2003CN1423693A Method for the production of vitamin A
06/11/2003CN1422947A Method for preparing self-aid fermentation substratum
06/10/2003US6576819 Methods for modulating the levels of organic sulfur compounds in plants by transforming with (P)APS reductase DNA
06/10/2003US6576818 Isolated polynucleotide of given sequence; use in altering the phenotype of cotton fiber
06/10/2003US6576816 Heavy metal phytoremediation
06/10/2003US6576815 Promoter sequence expressed in anthers and pollens
06/10/2003US6576753 Genomic clone of given sequence; can use in diagnosing susceptibility to asthma
06/10/2003US6576613 Title inhibitors of urokinase
06/10/2003US6576610 Includes substructure with thrombogenic potential operably linked to selective recognition domain; interacts with function forming context expressed by cells or tissues
06/10/2003US6576609 Methods and compositions for generating angiostatin
06/10/2003US6576467 Methods for producing recombined antibodies
06/10/2003US6576455 Structure-based designed herbicide resistant products
06/10/2003US6576454 One or more amino acid residues being replaced by cysteine residues where at least some of cysteine residues are modified by replacing thiol hydrogen in cysteine residue with thiol side chain to form modified enzyme
06/10/2003US6576453 Thermostable DNA ligase mutants
06/10/2003US6576452 Isolated nucleic acid molecule comprising a nucleotide sequence which encodes a polypeptide of given amino acid sequence; use for biological conversion of glucose to ascorbic acid
06/10/2003US6576439 Contacting protein of given sequence with a test compound and detecting modulating activity; drug screening; can use for treatment of inflammatory conditions
06/10/2003US6576437 Stimulus-inducible protein kinase complex and methods of use therefor
06/10/2003US6576436 Anticancer agents based on prevention of protein prenylation
06/10/2003US6576427 Human cartilage glycoprotein
06/10/2003US6576271 Method for inhibiting inflammation using bioflavonoids
06/10/2003US6576245 Primary package containing aqueous solution for parenteral administration comprising low molecular weight peptide-based thrombin inhibitor or salt,and having specified pH, sealed with rubber stopper or plunger containing bromobutyl rubber
06/10/2003US6576235 Conjugate of purified uricase, retaining at least about 75% of uricolytic activity of unconjugated uricase and reduced in immunogenicity, in which each subunit of uricase is covalently linked to 2 to 10 strands of polyoxyethylene glycol
06/10/2003US6576234 Reovirus for the treatment of neoplasia
06/10/2003CA2120020C Air treatment plant for foodstuff comprising a trough with an adjustable width
06/10/2003CA2076652C Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase
06/05/2003WO2003046556A2 Globin biopolymer markers indicative of insulin resistance
06/05/2003WO2003046196A1 Secreted proteins
06/05/2003WO2003046190A1 Optimized production of viral vectors derived from paroviruses in packaging and production cells by hsv infection or treatment with dna methylation inhibitors
06/05/2003WO2003046169A2 Xylanases with enhanced thermophilicity and alkalophilicity